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Abstract
Background: Health-related quality of life (HRQOL) is a key outcome in arthritis, but few
population-based studies have examined the relationship of specific arthritic conditions, such as
osteoarthritis (OA) and rheumatoid arthritis (RA) with HRQOL.
Methods: Older adults in Pennsylvania completed a mail version of the Centers for Disease
Control and Prevention (CDC) HRQOL modules. Medicare data were used to identify subjects
with OA, RA, and no arthritis diagnosis. We compared HRQOL responses among these groups,
and we also examined relationships of demographic characteristics to HRQOL among subjects with
arthritis.
Results: In analyses controlling for demographic characteristics and comorbidity, subjects with OA
and RA had poorer scores than those without arthritis on all HRQOL items, including general
health, physical health, mental health, activity limitation, pain, sleep, and feeling healthy and full of
energy. HRQOL scores were also lower for those with RA compared to OA. Among individuals
with arthritis, all subject characteristics (including age, race, sex, nursing home residence, marital
status, income, and comorbid illnesses) were significantly related to at least one HRQOL item.
Older age, nursing home residence, and greater comorbidity were the most consistently associated
with poorer HRQOL.
Conclusions: Results of this study show that both OA and RA have a significant impact on multiple
dimensions of HRQOL among older adults. Results also suggest the CDC HRQOL items are
suitable for use among older adults and in mail surveys. Due to the rising number of older adults
in many countries, the public health burden of arthritis is expected to increase dramatically. Efforts
are needed to enhance access to medical care and disseminate self-management interventions for
arthritis.
Background
Arthritis is one of the most common chronic diseases and
a leading cause of disability in the United States (U.S.),
and other developed countries [1-8]. In the U.S., 55% of
individuals age 65 and older report having arthritis or
chronic joint symptoms [9]. Due to the increasing
number of older adults in many countries, the prevalence
of arthritis is expected to rise dramatically [1,8,10-13]. In
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the U.S., it is estimated that the prevalence of arthritis will
rise from 43 million in 1997 to 60 million in 2020
[12,13]. In Canada, it is projected that the prevalence of
arthritis will increase from 2.9 million to 6.5 million
between 1991 and 2031 [8]. These estimates portend a
mounting public health burden.
Because of this growing epidemic, it is important to
understand and monitor the impact of arthritis on health
outcomes. One health outcome of primary interest within
the context of arthritis is health-related quality of life
(HRQOL). Arthritis can affect a variety of physical and
psychological health domains, and HRQOL measures
provide a broad picture of this impact. Therefore HRQOL
is now a standard, widely accepted measure in both clini-
cal trials and observational studies. A number of large
population- and community-based studies have exam-
ined the effects of arthritis on disability and physical func-
tion [14-19], but few have assessed overall HRQOL [20-
22]. One challenge to population-based assessment of
HRQOL is that the length of most traditional measures
makes widespread distribution (via telephone or mail)
cumbersome. However, the Centers for Disease Control
and Prevention (CDC) has developed a brief set of
HRQOL items that are now used routinely in the U.S.
Behavioral Risk Factor Surveillance System (BRFSS) and
other national surveys [23]. Analyses of BRFSS data have
shown that individuals with self-reported arthritis or
chronic joint symptoms have poorer HRQOL than those
without arthritis [20,24]. These HRQOL items have also
been shown to perform well in a clinical population of
individuals with rheumatic diseases[25].
In this study, we used the CDC measure to examine the
relationship of HRQOL with osteoarthritis (OA) and
rheumatoid arthritis (RA) among a statewide sample of
older adults. We also examined the relationship of demo-
graphic characteristics with HRQOL among older adults
with OA and RA. This study adds to previous findings in
several important ways. First, this study compared
HRQOL scores among a large sample of individuals with
physician diagnoses of specific diseases (OA and RA) to
individuals without these diagnoses. Previous studies of
HRQOL and arthritis have either relied on self reported
diagnosis [20-22,24] or have not included a group of indi-
viduals without rheumatic disease [25]. Second, this study
specifically involved older adults. Since older adults are
the demographic group most commonly affected by
arthritis, it is important to understand how OA and RA
influence HRQOL in this population. Third, this study
tested the feasibility of large-scale mail administration of
the CDC HRQOL items, which are most commonly
administered via phone. Fourth, this study involved link-
age of HRQOL survey data with diagnosis codes from
administrative medical databases. This methodology can
be used by health care systems and government organiza-
tions to examine HRQOL in large samples of individuals
with other chronic diseases.
Methods
Subjects
All subjects were enrolled in Pennsylvania's Pharmaceuti-
cal Assistance Contract for the Elderly (PACE). PACE is a
state program that helps to pay for prescription medica-
tions for Pennsylvanians age 65 and older whose annual
income does not exceed $17,200 if married or $14,000 if
single. During 1997, HRQOL surveys were included with
PACE applications mailed to cardholders who were sched-
uled to renew their coverage. Among the 161,851 individ-
uals who reapplied for coverage, 84,065 returned
completed surveys. Due to complications in survey
processing during April, surveys were not sent out with all
PACE renewal applications during this month. Therefore,
individuals scheduled to reapply for PACE benefits during
April were excluded when calculating a survey response
rate. Out of the 144,819 individuals who reapplied for
PACE benefits in months other than April, 83,471
returned surveys, resulting in a 57.6 % response rate.
Respondents and non-respondents were similar with
respect to demographic characteristics including age, gen-
der, race, residential status, marital status, and annual
income.
Arthritis diagnoses for the current study were based on
Medicare Part B (Physician/Supplier) claims occurring
within one year prior to subjects' survey completion. Only
subjects with complete Medicare Part B data for the year
prior to survey completion were eligible for this study.
Approximately 49% of survey respondents were excluded
because they were either not Medicare eligible for the full
year prior to survey completion or were members of a
health maintenance organization (HMO) that processed
their Medicare claims. This resulted in a final study sam-
ple of 41,467. HMO enrollment was a considerable
source of ineligibility. For example, approximately 24% of
survey respondents were enrolled in an HMO for at least
one month of 1997. Subjects with complete Medicare
data were similar to subjects excluded due to incomplete
Medicare data with regard to age, race, income, and resi-
dential subjects. However, subjects with complete Medi-
care data were more likely to be male (23.6% vs. 20.5%, p
< 0.001) and were less likely to be married and living with
their spouse (16.9% vs. 4.4%, p < 0.001).
Arthritis Diagnoses
OA and RA were identified on the basis of International
Classification of Diseases, Version 9 (ICD-9) codes (715
and 714, respectively) from both principal and secondary
diagnosis fields within Medicare Physician/Supplier data
files. Individuals were placed into three categories: noHealth and Quality of Life Outcomes 2004, 2 http://www.hqlo.com/content/2/1/5
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arthritis diagnosis, OA diagnosis, and RA diagnosis.
Approximately 1% of individuals in sample had ICD-9
codes for both OA and RA during the year prior to survey
completion. HRQOL scores of individuals with both OA
and RA were similar to those for individuals with an RA
diagnosis code only. Because of the small sample size of
this group, they were combined with individuals with an
RA diagnosis code only.
Demographic Factors and Comorbidity
Demographic characteristics included in these analyses
were age, gender, annual income (treated as a continuous
variable), marital status (married and living with spouse
vs. other), residential status (nursing home vs. commu-
nity dwelling), and race. The sample was predominantly
(94%) white, with small proportions of other racial/eth-
nic groups (5% African American, and <1% of each of the
following groups: Asian, Hispanic, Indian, and other –
not otherwise described). Therefore we examined race as
a dichotomous variable – white and non-white. All demo-
graphic factors were obtained from the PACE Enrollment
History File. Comorbidity was assessed via the Charlson
Comorbidity Score, which uses ICD-9 codes to identify
specific diseases [26,27]. The Charlson Score gives greater
weight to mores severe illnesses. For this study, subjects'
outpatient visits (Medicare Part B) occurring within one
year prior to participants' survey completion date were
used to derive the Charlson Score. The Charlson Score was
treated as a continuous variable in all analyses.
Survey Instrument
HRQOL was assessed via a mail version of the CDC's Core
and Optional HRQOL Modules. In this study, we exam-
ined nine items from the CDC HRQOL measure (Appen-
dix A; See Additional File 1). These HRQOL items have
been shown to be internally consistent and to identify
unmet health-related needs, health disparities, and health
behaviors [23,28-30]. Four of these items (numbers 1–4
in Appendix A) are part of the Core HRQOL module,
which is administered to all BRFSS participants. The five
remaining questions are part of a 10-item Optional Mod-
ule that measures more detailed aspects of HRQOL. We
selected these additional five items because of their rele-
vance to arthritis. For the general health item (number 1
in Appendix A), we grouped responses into two catego-
ries: excellent, very good, or good health compared to fair
or poor health. Two additional items, presence of a
health-related activity limitation (number 8 in Appendix
A) and needing help with personal care (number 9 in
Appendix A), were treated as binary (yes/no) variables.
The remainder of the HRQOL items were treated as con-
tinuous variables, with a minimum score of 0 days and a
maximum score of 30 days.
Statistical Analyses
First, we examined relationships of arthritis diagnoses to
each HRQOL item. We used Analysis of covariance
(ANCOVA) models to compare continuous HRQOL
items among subjects with no arthritis, OA diagnosis, and
RA diagnosis, while controlling for covariates listed
above. Similarly, we used logistic regression models (for-
ward selection) to compare dichotomous HRQOL items
across arthritis diagnosis groups, controlling for all covari-
ates. Second, we examined relationships of demographic
characteristics and comorbidity with HRQOL among sub-
jects with OA and RA. For these analyses, we examined
five representative HRQOL items, including the four Core
CDC items and the pain item (because of its particular rel-
evance to arthritis). We used logistic regression (forward
selection) to examine relationships of subject characteris-
tics with the dichotomous general health variable, and we
used ANCOVA models to examine the four continuous
HRQOL items. Statistical significance was set at p < 0.05
for all analyses, which were performed using Statistical
Analysis System (SAS) version 8.0.
Results
Among the 41,467 eligible survey respondents, 26.4% (N
= 10,923) had an ICD-9 code for OA and/or RA during the
year prior to survey completion (Table 1). Specifically,
24% of respondents had a diagnosis code for OA and
2.4% had a diagnosis code for RA (approximately half of
whom also had a diagnosis code for OA). In analyses
adjusted for demographic characteristics and comorbid-
ity, subjects in both arthritis groups had significantly
poorer HRQOL on all six "days" items (Table 2) com-
pared to subjects with no arthritis diagnosis. For subjects
in both arthritis groups, the HRQOL item that differed
most from subjects with no arthritis was the number of
days of pain. Compared to those with no arthritis, subjects
with OA reported 3.7 more days of pain, and subjects in
the RA group reported 6.6 more days of pain. The smallest
group differences were observed in the mental health
item, with subjects in the arthritis groups reporting
approximately one additional day of "not good" mental
health compared to subjects with no arthritis. In addition
to differences between subjects with arthritis and no
arthritis, there were significant differences in the "days"
HRQOL items between subjects in both arthritis groups.
Subjects in the RA group had poorer scores on each item,
and these differences were statistically significant for all
items except for mental health.
There were also statistically significant differences among
diagnosis groups for each of the categorical HRQOL
items. Forty-nine percent of individuals with no arthritis
diagnosis reported fair or poor general health, compared
with 55% of subjects with OA and 66% of subjects with
RA (p < 0.001). In the logistic regression modelHealth and Quality of Life Outcomes 2004, 2 http://www.hqlo.com/content/2/1/5
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controlling for demographic characteristics and comor-
bidity, there were statistically significant differences
between all three groups (p < 0.01; Table 3). Fifty-seven
percent of subjects without arthritis reported that their
activities were limited because of some impairment or
health problem, compared with 67% of subjects with OA
and 79% of subjects with RA (p < 0.001). In a multivaria-
ble logistic regression model, there were statistically sig-
nificant differences among all three groups (p < 0.01).
Twenty-two percent of subjects with no arthritis diagnosis
reported needing help with personal care, compared with
25% of subjects with OA and 32% of subjects with RA (p
< 0.001). In the multivariable logistic regression model,
subjects with RA had significantly greater odds of needing
help with personal care than subjects without arthritis and
those with OA (p < 0.01). However, there were no statis-
tically significant differences between subjects with OA
and those without arthritis.
Among subjects with arthritis (OA and/or RA), there were
some differences in HRQOL according to demographic
characteristics and comorbidity (Table 4). Subjects who
were more likely to report fair or poor general health
included those who were older, non-whites, nursing
Table 1: Demographic Characteristics of Sample
All Subjects (N = 41,467) No Arthritis Diagnosis (N = 
30,544)
Arthritis Diagnosis (N = 
10,923)
Male (%) 23.6 17.3 25.8
Mean Age (SD) 79.1 (6.9) 79.9 (6.8) 78.8 (6.9)
Mean (SD) Annual Income $11,108 (3,008) $10,998 (2,894) $11,114 (3,048)
White (%) 93.6 93.1 93.8
Married (%) 16.9 14.2 17.8
Community-Dwelling (%) 96.3 95.6 96.5
Mean (SD) Charlson Comorbidity 
Score
2.1 (1.6) 2.5 (1.5) 2.0 (1.5)
*All comparisons significant at the p < 0.01 level.
Table 2: Mean HRQOL Responses According to Arthritis Diagnosis
"Not Good" 
Physical Healtha
"Not Good" 
Mental Healthb
Activity 
Limitationa
Paina Poor Sleepa Feeling Very 
Healthya
No Arthritis 7.9 (11.4) 4.2 (8.9) 5.8 (10.5) 6.4 (10.7) 5.0 (9.1) 10.7 (12.4)
OA Diagnosis 10.3 (12.2) 4.8 (9.4) 7.4 (11.4) 10.1 (12.4) 6.3 (9.9) 8.8 (11.6)
RA Diagnosis 12.3 (12.6) 5.2 (9.6) 9.1 (12.1) 13.0 (13.1) 7.2 (10.4) 6.7 (10.5)
Note: Analysis of covariance models adjusted for age, gender, race, income, marital status, residential status, and comorbidity. All responses are 
scored as the number of days out of the previous 30. a Statistically significant differences between all three diagnosis groups (p < 0.05). b Statistically 
significant differences between no arthritis group and those with OA and RA (p < 0.05), but no significant difference between OA and RA groups.
Table 3: Categorical HRQOL Responses According to Arthritis Diagnosis
Fair or Poor General Healtha Any Health-Related Activity 
Limitationa
Need Help with Personal 
Careb
OR (95% CI) OR (95% CI) OR (95% CI)
No Arthritis 1.0 1.0 1.0
OA Diagnosis 1.12 (1.07–1.78) 1.38 (1.30–1.45) 0.98 (0.92–1.05)
RA Diagnosis 1.36 (1.18–1.58) 2.00 (1.69–2.38) 1.27 (1.07–1.50)
Note: Analysis of covariance models adjusted for age, gender, race, income, marital status, residential status, and comorbidity. a Statistically 
significant differences between all three diagnosis groups (p < 0.01). b Statistically significant differences between RA and other two groups (p < 
0.01). No significant difference between OA and those with no arthritis.Health and Quality of Life Outcomes 2004, 2 http://www.hqlo.com/content/2/1/5
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home residents, married subjects, those with lower
income, and those with more comorbid illnesses. Subjects
who were 85 years and older, male, residing in a nursing
home, married, and had lower income and more comor-
bid illnesses reported poorer scores on one or more of the
"days" HRQOL items. Subject race was not significantly
related to any of the "days" items.
Discussion
In agreement with prior research [20,22,24,31], results of
this study show that arthritis has a significant impact on
multiple dimensions of HRQOL. Specifically, older adults
with OA and RA reported poorer general health, physical
health, mental health, and sleep, as well as more activity
limitation and pain, compared to those without arthritis.
These results also confirm that arthritis differentially
impacts specific aspects of HRQOL. Not surprisingly, pain
showed the largest difference between subjects with
arthritis and without arthritis. Although the sleep and
mental health items showed statistically significant differ-
ences across groups, the magnitude of these differences
was small (1–2 days) and of questionable clinical rele-
vance. Mili et al. reported a similar difference in "not
good" mental health days between subjects without
arthritis and those reporting doctor-diagnosed arthritis in
the BRFSS sample [24]. Yet studies using other measures
have shown that depression is a substantial problem
among individuals with arthritis particularly RA [32].
Subjects with OA and RA in this sample had considerably
poorer HRQOL than individuals in the BRFSS sample
who were ≥ 65 years of age and reported having arthritis
[24]. For example, 40% of the BRFSS sample reported fair
or poor general health, compared with 55% of subjects
with OA and 66% of subjects with RA in our sample. In
the BRFSS group, the mean number of days of activity lim-
itation was 3.5, compared with 10 days in our OA group
and 13 days in our RA group. These differences may be
partially due to the definitions of arthritis used in these
two studies. In the BRFSS study, the arthritis sample was
defined as those reporting either the presence of chronic
joint symptoms or a doctor's diagnosis of arthritis. The
present study used ICD-9 codes from medical records, so
all patients were under physician care for OA. Since all
participants in the BRFSS sample did not report having a
doctor's diagnosis, this may have been a sample with a
lower average level of OA severity than our sample. How-
ever, demographic and health characteristics of the
Table 4: Relationship of Subject Characteristics to HRQOL among Those with Arthritis
Fair or Poor 
General Health
Days of "Not 
Good" Physical 
Health
Days of "Not 
Good" Mental 
Healthb
Days of Activity 
Limitationa
Days of Paina
OR (95% CI) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Age group
65–74 1.00 10.1 (12.0) 4.5 (9.0) 6.7 (10.8) 9.7 (12.1)
75–84 1.56 (1.39–1.75)b 10.2 (12.1) 4.5 (9.1) 7.1 (11.1) 10.0 (12.4)
85+ 1.20 (1.09–1.32)b 11.6 (12.7)b 5.9 (10.4)b 9.5 (12.6)b 11.9 (13.1)b
Sex
Women 1.00 10.2 (12.1) 4.7 (9.3) 7.5 (11.4) 10.4 (12.5)
Men 1.07 (0.95–1.20) 11.6 (12.8)b 5.4 (9.8)b 8.3 (11.8) 10.5 (12.6)
Race
White 1.00 10.5 (12.2) 4.8 (9.4) 7.6 (11.5) 10.4 (12.5)
Non-white 1.49 (1.27–1.76)b 11.0 (12.4) 5.0 (9.4) 8.0 (11.6) 10.7 (12.4)
Residence
Nursing Home 1.00 15.3 (13.3) 11.7 (13.2) 15.5 (13.9) 15.3 (13.7)
Community 0.56 (0.45–0.70)b 10.3 (12.1)b 4.5 (9.1)b 7.2 (11.2)b 10.2 (12.4)b
Marital Status
Non-married 1.00 10.3 (12.2) 4.8 (9.3) 7.5 (11.4) 10.3 (12.5)
Married 1.39 (1.21–1.59)b 11.4 (12.5)b 5.4 (9.8) 8.0 (11.7) 10.8 (12.6)
Incomea
Lower 1.00 10.5 (12.3) 4.8 (9.3) 7.8 (11.6) 10.7 (12.7)
Higher 0.89 (0.81–0.97)b 10.5 (12.4) 4.9 (9.5) 7.4 (11.4) 10.1 (12.4)b
Comorbid Illness
0–1 1.00 7.2 (10.8) 3.1 (7.6) 4.5 (9.2) 7.5 (11.3)
2 2.87 (2.60–3.16)b 10.0 (11.9)b 4.6 (9.1)b 7.0 (11.0) 10.3 (12.5)b
3+ 1.72 (1.56–1.91)b 13.5 (10.8)b 6.5 (10.6)b 10.6 (12.7) 12.8 (13.0)b
aIncome divided at 50th percentile ($10,800)bSignificantly different from referent category (p < 0.05) in multivariable analysis.Health and Quality of Life Outcomes 2004, 2 http://www.hqlo.com/content/2/1/5
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samples may also be related to the observed differences.
Even among those without arthritis, HRQOL was poorer
in the current study compared to the BRFSS sample. Our
sample consisted of older adults with fairly low income
levels, and they may been in generally poorer health than
those in the BRFSS. It is significant that even in our sample
of older adults with relatively low income and multiple
comorbid illnesses, a diagnosis of arthritis was associated
with poorer HRQOL. This suggests an important inde-
pendent impact of arthritis on HRQOL among older
adults.
Also in agreement with prior studies [21,22,25], this study
revealed poorer HRQOL among individuals with RA com-
pared to OA. Individuals with RA had poorer scores than
those with OA on all HRQOL items, though this differ-
ence was not statistically significant for days of "not good"
mental health. In general, RA is associated with greater
disability than OA, though individuals with more severe
OA and widespread pain may have comparable impair-
ment [21]. Although HRQOL may be lower for individu-
als with RA than OA, this study shows that OA also has a
significant impact on HRQOL. Furthermore, the high
prevalence of OA makes this a considerable public health
concern.
Among subjects with OA and RA in this sample, we found
that HRQOL differed according to demographic charac-
teristics and comorbidity. These associations were largely
in the expected direction and similar to other research
[24,33], with older age, non-white race, nursing home res-
idence, lower income, and greater comorbidity being
associated with poorer scores on at least one HRQOL
item. In contrast to other research [24], men in this sam-
ple reported a greater number of days of "not good" phys-
ical and mental health compared with women. The reason
for this association is not clear, but men in this sample
may have had greater arthritis severity or overall poorer
health (which was not captured adequately by the Charl-
son Comorbidity Score) compared to women.
This study also confirmed the utility of the CDC's HRQOL
items for mail distribution and among older adults. This
scale differentiated between individuals with arthritis and
without arthritis, and it also detected differences between
those with OA and RA. Because the CDC HRQOL Mod-
ules are brief and easy to administer by telephone or mail,
they are particularly useful for large-scale epidemiological
studies.
There are several limitations so this study. Compared to
the general U.S. elderly population, PACE enrollees are
older and have a lower annual income. PACE enrollees
also include a greater proportion of females, a smaller per-
centage of minorities, and a smaller proportion of mar-
ried individuals. This sample was also restricted to
subjects with complete Medicare data during the observa-
tion period. These individuals were also less likely to be
married than subjects who were excluded because of
incomplete Medicare data. These sample characteristics
may limit generalizability, and additional studies are
needed among different samples of older adults. Because
of the very small numbers (<20) in some racial/ethnic
groups, it was not possible to examine differences across
specific groups. We used a broad race categorization
(white vs. non-white) that may have masked differences
in some specific racial/ethnic groups, and further study is
needed on more racially diverse samples.
Another limitation concerns the specificity of ICD-9 codes
for OA. Studies have reported the sensitivity of ICD-9
codes for OA to be between 0.32 and 1.0, and the positive
predictive value between 0.76 and 0.90 [34,35]. Sensitiv-
ity and positive predictive value are both greater when
codes are used to identify OA in general (as was done in
this study), rather than site-specific OA. Because of these
known issues regarding ICD-9 code accuracy, there may
have been some misclassification in this study. However,
there are also inaccuracies associated with self-reported
diagnosis of arthritis, and radiographic evidence is not
feasible for samples of this size.
A limitation of all survey studies is the potential for non-
response bias. The response rate for this survey was similar
to the average response rate in other published studies
involving mail surveys [36]. Non-respondents were
similar to respondents on a variety of demographic char-
acteristics. Though this survey was brief (16 questions),
older adults with poorer health or greater functional lim-
itation may have been less likely to complete the survey.
Therefore this sample may under-represent older adults
with poorer health and possibly greater arthritis severity.
In summary, this study revealed a substantial impact of
OA and RA on HRQOL, as measured by the CDC items.
Both pharmacological and non-pharmacological treat-
ments can yield improvements in arthritis symptoms and
HRQOL [37]. However, both medical treatment and non-
pharmacological interventions are underutilized [38-40],
and some evidence suggests that medications are often
prescribed at doses that may be too low to optimally affect
symptoms [41]. Efforts are needed to enhance access to
medical care for OA, ensure optimal pharmacological
management, and disseminate self-management
interventions.
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